Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1607148436;48437;48438 chr2:178616580;178616579;178616578chr2:179481307;179481306;179481305
N2AB1443043513;43514;43515 chr2:178616580;178616579;178616578chr2:179481307;179481306;179481305
N2A1350340732;40733;40734 chr2:178616580;178616579;178616578chr2:179481307;179481306;179481305
N2B700621241;21242;21243 chr2:178616580;178616579;178616578chr2:179481307;179481306;179481305
Novex-1713121616;21617;21618 chr2:178616580;178616579;178616578chr2:179481307;179481306;179481305
Novex-2719821817;21818;21819 chr2:178616580;178616579;178616578chr2:179481307;179481306;179481305
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCA
  • RefSeq wild type template codon: AGT
  • Domain: Fn3-4
  • Domain position: 17
  • Structural Position: 19
  • Q(SASA): 0.1302
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/L rs794727332 0.371 0.669 D 0.56 0.438 None gnomAD-2.1.1 8.07E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.78E-05 0
S/L rs794727332 0.371 0.669 D 0.56 0.438 None gnomAD-4.0.0 2.19121E-05 None None None None N None 2.99509E-05 0 None 0 0 None 0 0 2.7E-05 0 1.65876E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0875 likely_benign 0.0952 benign -0.539 Destabilizing 0.454 N 0.391 neutral D 0.539984933 None None N
S/C 0.0855 likely_benign 0.1161 benign -0.644 Destabilizing 0.998 D 0.613 neutral None None None None N
S/D 0.5742 likely_pathogenic 0.6696 pathogenic -1.414 Destabilizing 0.842 D 0.516 neutral None None None None N
S/E 0.5724 likely_pathogenic 0.6772 pathogenic -1.342 Destabilizing 0.842 D 0.481 neutral None None None None N
S/F 0.1955 likely_benign 0.2763 benign -0.583 Destabilizing 0.974 D 0.68 prob.neutral None None None None N
S/G 0.1131 likely_benign 0.1458 benign -0.849 Destabilizing 0.688 D 0.467 neutral None None None None N
S/H 0.2678 likely_benign 0.3953 ambiguous -1.471 Destabilizing 0.016 N 0.295 neutral None None None None N
S/I 0.2727 likely_benign 0.3592 ambiguous 0.192 Stabilizing 0.949 D 0.657 neutral None None None None N
S/K 0.5694 likely_pathogenic 0.7116 pathogenic -0.813 Destabilizing 0.842 D 0.516 neutral None None None None N
S/L 0.1337 likely_benign 0.1583 benign 0.192 Stabilizing 0.669 D 0.56 neutral D 0.648318702 None None N
S/M 0.1678 likely_benign 0.2344 benign 0.316 Stabilizing 0.991 D 0.625 neutral None None None None N
S/N 0.1779 likely_benign 0.2388 benign -1.153 Destabilizing 0.842 D 0.502 neutral None None None None N
S/P 0.9796 likely_pathogenic 0.986 pathogenic -0.016 Destabilizing 0.966 D 0.643 neutral D 0.736505982 None None N
S/Q 0.4468 ambiguous 0.5922 pathogenic -1.171 Destabilizing 0.974 D 0.583 neutral None None None None N
S/R 0.4576 ambiguous 0.5916 pathogenic -0.875 Destabilizing 0.842 D 0.617 neutral None None None None N
S/T 0.0736 likely_benign 0.0835 benign -0.879 Destabilizing 0.022 N 0.195 neutral N 0.483820019 None None N
S/V 0.2415 likely_benign 0.3228 benign -0.016 Destabilizing 0.728 D 0.565 neutral None None None None N
S/W 0.4273 ambiguous 0.5474 ambiguous -0.775 Destabilizing 0.998 D 0.709 prob.delet. None None None None N
S/Y 0.1847 likely_benign 0.2512 benign -0.398 Destabilizing 0.949 D 0.657 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.